MedWatch

New product will positively impact sales prognosis, says CEO at GN Hearing

The delayed hybrid product Jabra Enhance Plus will finally hit the shelves in the US later this month, and the launch will affect sales projections for the better, CEO Gitte Aabo says ahead of the company’s 2022 guidance on Thursday.

Gitte Aabo, CEO of GN Hearing | Photo: BUNDGAARD CARSTEN/ERH

It was with great relief that GN Hearing’s management could unveil the launch of Jabra Enhance Plus, the company’s hybrid between a true wireless earbud and a hearing aid, on Tuesday. The rollout begins on February 25 in the US.

The product, which is based on technology from both GN Hearing and its sister company GN Audio, was originally meant to hit US shelves in the second half of last year, but research and development letdowns put an end to that ambition.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs